This week, Goodness Growth, a multi-state cannabis operator formerly known as Vireo Health, announced the pending acquisition by Verano Holdings. I have been discussing for quite some time that the company was likely to be acquired, providing my subscribers at 420 Investor a rationale, as detailed below. Here is how the stock performed subsequently (including a comparison to ETF MSOS, a good proxy):
I am sharing my most recent analysis, which was part of the December edition of the 420 Investor Newsletter (and shared with full-service members ahead of publication) so that you can understand the value I provide to folks interested in understanding and potentially investing in the cannabis industry. My goal is to educate and inform, highlighting risks and opportunities.
If you are interested in the cannabis sector, I can help you navigate its complexity and volatility.
To subscribe to the monthly 420 Investor Newsletter ($199 per year):
The full 420 Investor service includes not only the monthly newsletter but also chat, alerts, model portfolios, a form and more (or to upgrade if you subscribe to the Newsletter already). The cost is $599 per year, and Newsletter subscribers will receive a credit for the remaining portion of their current subscription:
Below is the most recent discussion of Goodness Growth (I have omitted the other 5 names):
Approaching the Focus List from a Value Investing Perspective
Posted on Nov. 21, 2021, 8:14 p.m.
This is the third of three feature articles for the upcoming December edition of the 420 Investor Newsletter.
2021 has been a year of round-trip for cannabis stocks. This has been a mirror of 2020, which started off with prices plunging and then soaring. When the Global Cannabis Stock Index bottomed in March 2020, it was then down 60% year-to-date. Worse, it ...